Her2 is an EGF receptor family member that drives proliferation of cells including in the breast. Too much Her2 signaling can contribute to Her2 positive breast cancer. Mutations can be generated in different proteins in the Her2 signaling pathway. The following are 5 different possible mutations.
Mutant a: Ras protein that cannot exchange GDP for GTP.
Mutant b: RAF protein with a mutation in the active site such that ATP does not bind.
Mutant c: Her2 receptor that lacks tyrosines in its intracellular domain.
Mutant d: MAPK that is constitutively active.
Mutant e: Myc expressed 10X higher than normal.
The following cell lines with mutations in Her2, Ras/MAPK pathway are treated with the ligand for the Her2 receptor and compared to normal cells treated with ligand. For each Her2 mutant pathway cell line, describe whether myc synthesis is higher or lower compared to normal cells and if proliferation (cell division) is higher or lower compared to normal cells treated with ligand
A. Cell line with mutations a and b.
B. Cell line with mutations c and e
C. Cell line with mutations d and e
D. Rb is also important for regulation of the cell cycle at the restriction point or start. What would be the effect on myc and cell proliferation of a mutation that switched all the serines and threonines that are phosphorylated to alanine?